CareMax receives Nasdaq delisting notice for failure to meet $15M MVPHS; appoints director Edward Borkowski
CareMax, Inc.
On Sept 20, 2024, Nasdaq notified CareMax that MVPHS for Class A common stock fell below $15M for 30 consecutive business days, violating Listing Rule 5450(b)(3)(C).
Company has 180 calendar days until March 19, 2025 to regain compliance by achieving closing MVPHS >= $15M for at least 10 consecutive business days.
If compliance is not regained, Nasdaq will delist the Common Stock; company may consider options but no assurance of success.
Board appointed Edward J. Borkowski as Class II director effective Sept 24, 2024, serving until 2026 annual meeting, with $45,000 per month compensation.
On and effective as of September 24, 2024, the board of directors (the “Board”) of the Company appointed Mr. Edward J. Borkowski to serve as a Class II director of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Edward J. Borkowski was appointed as Class II director at CareMax, Inc..
Action
appointed
Role
Class II director
Exact text from the filing
On and effective as of September 24, 2024, the board of directors (the “Board”) of the Company appointed Mr. Edward J. Borkowski to serve as a Class II director of the Board.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.